Statements suggesting GLP-1 supplements are alternatives to prescription drugs or offer similar outcomes may violate FDA and FTC advertising regulations
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in GLP1R, GIPR, FTO, and MC4R pathways to provide genetic context for how your metabolic system may respond to GLP-1 compounds
The FDA has reported adverse-event concerns involving compounded semaglutide and tirzepatide, including dosing errors, gastrointestinal symptoms, and events that required medical attention
138 Recommended treatments for MASLD, including lean MASLD, still emphasize lifestyle interventions such as diet and exercise for weight loss
The medication essentially modulates how your digestive system processes and moves food, which can disrupt normal bowel patterns